Skip to main content
OpenTrials

Clinical trial condition

Triple Negative Breast Neoplasms

Explore clinical trials studying Triple Negative Breast Neoplasms. Study availability and eligibility vary by location and protocol.

39 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Triple Negative Breast Neoplasms trial results

Not Yet Recruiting

Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" Study

NCT05067530

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Wielkopolskie Centrum Onkologii im. Marii Skłodowskiej-Curie, Oddział Onkologii Klinicznej i Immunoonkologii z Pododdziałem Dziennym Poznan, Greater Poland Voivodeship, Poland
  • Dolnośląskie Centrum Onkologii we Wrocławiu, Oddział Onkologii Klinicznej/Chemioterapii, Poradnia Chemioterapii; Leczenie Nowotworów Piersi Wroclaw, Lower Silesian Voivodeship, Poland
  • Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Warsaw, Masovian Voivodeship, Poland
  • SP ZOZ Opolskie Centrum Onkologii im. Prof. Tadeusza Koszarowskiego Opole, Opole Voivodeship, Poland
View Trial Details
Completed

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

NCT04191135

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • Pacific Cancer Care ( Site 0142) Monterey, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center ( Site 0138) San Francisco, California, United States
  • John Wayne Cancer Institute ( Site 0111) Santa Monica, California, United States
  • St. Joseph Heritage Healthcare ( Site 0104) Santa Rosa, California, United States
View all 122 locations
View Trial Details
Completed

Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

NCT03310957

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cedars Sinai Medical Center / Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center University of California Irvine Orange, California, United States
  • University of California Irvine - Newport Orange, California, United States
View all 50 locations
View Trial Details
Completed

Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab

NCT02926196

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
Locations
  • Ospedale di Bergamo Bergamo, BG, Italy
  • Policlinico Sant'Orsola Malpighi Bologna, BO, Italy
  • Ospedale di Bellaria Bologna, BO, Italy
  • Azienda Sanitaria Locale Brindisi Brindisi, BR, Italy
View all 70 locations
View Trial Details

Related conditions